Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Does US FDA Need An Independent Commission To Analyze Its Pandemic Response?
21 May 2021
•
By
Derrick Gingery
Former FDA commissioners Andrew von Eschenbach, Robert Califf and Mark McClellan discuss how the pandemic changed the agency with FDLI President and CEO Amy Comstock Rick. • Source: Screenshot
More from Agency Leadership
More from Pink Sheet